Joshua Lehrer-Graiwer, Chief Medical Officer at Global Blood Therapeutics, Inc. (GBT), sold 8,196 shares at $62.81 ($524K) on 2020-02-03, disclosed to the SEC on 2020-02-04.
Open-market sale of $524k GBT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.26 | 2,163 | $141K | 27.0% |
| 2 | $62.81 | 2,188 | $137K | 26.2% |
| 3 | $62.81 | 2,188 | $137K | 26.2% |
| 4 | $65.00 | 1,657 | $108K | 20.6% |
| Total | $63.90 avg | 8,196 | $524K | 100% |
| Filing → |
| GBT | SELL | 2020-02-10 | $614K | — | Filing → |
| GBT | SELL | 2020-01-29 | $111K | — | Filing → |
| GBT | SELL | 2019-12-11 | $147K | — | Filing → |